Today AEMD ranks # as SELL CANDIDATE.
Today AEMD ranks # as SELL CANDIDATE.

AEMD stock Aethlon Medical

AEMD stock
Aethlon Medical

23 January 2019
Change -1.63%
Chart period: 2018-10-24 - 2019-01-23
VOLUME
Sell
TREND
Buy

MV LONG
Sell

MV SHORT
Sell

PIVOT
Sell

MACD
Sell
Request Prediction
Predict

Aethlon Medical Stock Analysis

Technical stock analysis for 23 January 2019

Sell candidate since 2019-01-22 Loss -1.63%
Shorts n/a
Cash n/a
Loans n/a
Beta 1.14
ROA -158.09

Aethlon Medical fell by -1.63% in the last day from $1.36 to $1.34 and has now fallen 3 days in a row. The price has fallen in 6 of the last 10 days and is down by -10.81% for this period. Volume fell in the last day along with the stock, which is actually a good sign as volume should follow the stock. In the last day the trading volume fell by -10 244 shares and in total 36 623 shares bought and sold for approximately $48 997.90.

Close price at the end of the last trading day (Wednesday, 23rd Jan 2019) of the AEMD stock was $1.34. This is 1.63% less than the trading day before Tuesday, 22nd Jan 2019.

During day the stock fluctuated 10.00% from a day low at $1.30 to a day high of $1.43.

30 day high of the AEMD stock price was $1.71 and low was $1.28.
90 day high was $1.74 and low was $1.00.
52 week high for the Aethlon Medical - $2.04 and low - $0.82.

Trend

Aethlon Medical lies in the lower part of a very wide and strong rising trend in the short term, and this will normally pose a very good buying opportunity. A break down the bottom trend line at $1.33 will firstly indicate a slower raising rate, but may also be a early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 29.43% during the next 3 months and, with 90% probability hold a price between $1.73 and $2.28 at the end of this period.

Click here for today's Top 5 Trending Companies

Signals

There are few to none technical positive signals at the moment. Aethlon Medical holds sales signals from both short- and long-term moving averages. In addition, there is a general sales signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up there will be some resistance from the lines at $1.35 and $1.37. A break-up above any of these levels will issue buy signals. A sales signal was issued from a pivot top point on Friday January 18, 2019, which indicates further falls until a new bottom pivot has been found. Volume fell along with the price during the last trading day which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk. The very low volume increases the risk and reduces the other technical signals issued.

Access today's Top 5 Golden Star Companies

Relative Strength Index (RSI)

The stock currently holds a RSI14 at 28 and is oversold on RSI14. The stock being oversold is no guarantee for instant reaction up as some stocks may be oversold for a long time. It is important to review the previous RSI-history to get an indication of the RSI-sensitiveness.

Access full RSI 14 and RSI 21 lists

Support & Resistance

Aethlon Medical finds support from accumulated volume at $1.31.

Support: $1.31 Price: $1.34 Resistance: $1.40

Risk

This stock may move much during a day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.13 between high and low, or 10.00%. For the last week the stock has had a daily average volatility of 7.51%.

Aethlon Medical is oversold on RSI14 (28). Some stocks may drop long and hard while being oversold on RSI before turning, which increases the general risk.

Our recommended stoploss: We hold a sell evaluation for this stock. No stop-loss set.

Overall risk:

Very Low Low Medium High Very High

Evaluation

The Aethlon Medical stock holds several negative signals and despite the positive trend we believe Aethlon Medical will perform weak in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock. We have upgraded our recommendation for this stock since last evaluation from a Strong Sell Candidate to a Sell Candidate.

Today AEMD ranks # as SELL CANDIDATE.
Today AEMD ranks # as SELL CANDIDATE.